| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/10/2006 | US20060178350 7-(2-Cyclohexylidene-ethylidene)-spiro[4.5]decanes |
| 08/10/2006 | US20060178349 Compositions and therapeutic methods utilizing a combination of a 5-HT1F inhibitor and an NSAID |
| 08/10/2006 | US20060178348 Compositions and therapeutic methods utilizing a combination of a protein extravasation inhibitor and an NSAID |
| 08/10/2006 | US20060178347 Use of inhibitors of soluble epoxide hydrolase to synergize activity of COX and 5-LOX inhibitors |
| 08/10/2006 | US20060178346 sickle cell diseases, glaucoma; inhibit potassium flux in a cell, reduce the Gardos channel of erythrocytes, reduce sickle erythrocyte dehydration and/or delay the occurrence of erythrocyte sickling or deformation; 2-(2-Fluoro-phenyl)-2-(4-fluoro-phenyl)-N-hydroxy-2-phenyl-acetamidine |
| 08/10/2006 | US20060178345 Substituted alcohols useful in treatment of Alzheimer's disease |
| 08/10/2006 | US20060178344 Glucosamine and N-acetylglucosamine and methods of making the same fungal biomass |
| 08/10/2006 | US20060178343 Hydroxypropylated starch; hyperlipidemia; visceral fat accumulation inhibitor, blood triglyceride level rise inhibitor |
| 08/10/2006 | US20060178342 Hyaluronan as a cytotoxic agent, drug pre-sensitizer and chemo-sensitizer in the treatment of disease |
| 08/10/2006 | US20060178341 Composition comprising soluble glucan oligomer from saccharomyces cerevisiae is2 inhibiting the swine influenza (SIV) and transmissible gastroenteritis coronavirus (tgev) |
| 08/10/2006 | US20060178340 Composition comprising soluble glucan oligomer from saccharomyces cerevisiae is2 for immune activation or prevention and treatment of cancer and the preparation method thereof |
| 08/10/2006 | US20060178339 Forms crosslinked product through covalent bond between active ester group in side chain and active hydrogen-containing group selected from a hydroxy group, an amino group, and a thiol group upon contact with alkaline water; biodegradable, nontoxic, bioabsorbable; low risk of infection; medical equipment |
| 08/10/2006 | US20060178338 Use of 5-substituterd nucleosides for reinforcing the apoptotic effect of cytostatic drugs |
| 08/10/2006 | US20060178333 Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof |
| 08/10/2006 | US20060178330 Use of antisense oligonucleotides or siRNA to suppress expression of eIF-5A1 |
| 08/10/2006 | US20060178329 Rna sequence for therapy of cancer; control degradation and block transscription of messenger Rna that is translation product of target gene |
| 08/10/2006 | US20060178323 Methods for the treatment of chronic pain and compositions therefor |
| 08/10/2006 | US20060178322 Methods for indentifying compounds that modulate an enzyme involved in riboflavin metabolism in a pathogenic microorganism |
| 08/10/2006 | US20060178321 Methods for indentifying compounds that modulate an enzyme involved in reductive carboxylation in a pathogenic microorganism |
| 08/10/2006 | US20060178320 Methods for indentifying compounds that modulate an enzyme involved in thiamine metabolism in a pathogenic microorganism |
| 08/10/2006 | US20060178319 antibiotics; caprazamycin B is subjected to acid-hydrolysis |
| 08/10/2006 | US20060178318 Use of aurora kinase inhibitors for reducing the resistance of cancer cells |
| 08/10/2006 | US20060178317 Methods of increasing endogenous erythropoietin (EPO) |
| 08/10/2006 | US20060178316 Methods of increasing endogenous erythropoietin (EPO) |
| 08/10/2006 | US20060178314 Methods and compositions for treating atheroma, tumors and other neoplastic tissues |
| 08/10/2006 | US20060178307 Modulation of NMDA receptor currents via orexin receptor and/or CRF receptor |
| 08/10/2006 | US20060178305 Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereof |
| 08/10/2006 | US20060178295 androgen steroid conjugated with one or more mammalian proteins; diagnosis or treatment of solid cancer and hematological malignancies; exhibit a synergistic action together with a cytoskeleton-acting drug such as Taxol (reg); prostate cancer |
| 08/10/2006 | US20060178294 comprises a N-acyl sarcosine; for identifying and/or quantifying variants and aberrant forms of hemoglobin; cell-by-cell measurement for different red blood cell subpopulations such as in both mature red blood cells and reticulocytes simultaneously |
| 08/10/2006 | US20060177920 Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids |
| 08/10/2006 | US20060177901 Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy |
| 08/10/2006 | US20060177864 Methods for identifying drug combinations for the treatment of proliferative diseases |
| 08/10/2006 | US20060177861 Novel compositions and methods in cancer associated with altered expression of MCM3AP |
| 08/10/2006 | US20060177817 Nucleic acid having a sequence that is codon-optimized for high level expression in a yeast cell; proteins produced provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity |
| 08/10/2006 | US20060177531 Compositions that treat or inhibit pathological conditions associated with inflammatory response |
| 08/10/2006 | US20060177530 Method of treating diabetes type II |
| 08/10/2006 | US20060177528 Formulation Of A Mixture Of Free-B-Ring Flavonoids And Flavans As A Therapeutic Agent |
| 08/10/2006 | US20060177524 Ocular irrigating solution |
| 08/10/2006 | US20060177523 Administration of a thiol-based chemoprotectant compound |
| 08/10/2006 | US20060177520 Compositions and methods for reducing cytotoxicity and inhibiting angiogenesis |
| 08/10/2006 | US20060177518 Peracetic teat dip |
| 08/10/2006 | US20060177516 Food-supplement composition suitable for promoting iron absorption |
| 08/10/2006 | US20060177513 Embolization using poly-4-hydroxybutyrate particles |
| 08/10/2006 | US20060177512 Process for preparing formulations of lipid-regulating drugs |
| 08/10/2006 | US20060177511 Antiseptic compositions and methods |
| 08/10/2006 | US20060177510 Dual controlled release osmotic device |
| 08/10/2006 | US20060177508 Fast disintegrating tablet |
| 08/10/2006 | US20060177506 Release control compositions |
| 08/10/2006 | US20060177505 Cleaning composition in solid form |
| 08/10/2006 | US20060177504 Combination pain medication |
| 08/10/2006 | US20060177503 Bambuterol and integrin inhibitor combination and treatment method |
| 08/10/2006 | US20060177501 Film Coated Tablets Containing Ibuprofen |
| 08/10/2006 | US20060177500 Solid dispersion of tacrolimus |
| 08/10/2006 | US20060177499 Method for the manufacture of a pharmaceutical composition in the form of tablets containing a fibrate and tablets obtained according to the method |
| 08/10/2006 | US20060177498 Solid pharmaceutical composition comprising ramipril |
| 08/10/2006 | US20060177495 Polymer-lipid delivery vehicles |
| 08/10/2006 | US20060177493 Transdermal granisetron |
| 08/10/2006 | US20060177485 Animal feed composition for increased production of glutathione peroxidase and superoxide dismutase |
| 08/10/2006 | US20060177482 Self-assembled monolayer having a thickness of10 - 40 A, preferably containing an active agent, e.g., polypeptide, heparin, hyaluronic acid, or superoxide dismutase mimic, on a layer of polymer especially having a reactive substitutent, e.g., hydroxyl, amino, aldehyde, or isocyanate. |
| 08/10/2006 | US20060177481 Methods for forming regional tissue adherent barriers and drug delivery systems |
| 08/10/2006 | US20060177477 inhibiting infection in an indwelling catheter defining at least one lumen therethrough by infusing an aqueous catheter lock solution into a lumen of the catheter, the solution comprising citrate, methylene blue and a paraben dispersed or dissolved therein |
| 08/10/2006 | US20060177471 Topical personal care compositions and methods of use |
| 08/10/2006 | US20060177467 Use of incense or hydrogenation products for preventing and/or treating a cerebral ischemia and/or cerebral traumatic lesion |
| 08/10/2006 | US20060177457 Are designed to produce both Type 1 and Type 2 phototherapeutic effect at once using dual wavelength light source that will produce singlet oxygen and free radicals at the lesion of interest; for dual phototherapy of tumors and other lesions |
| 08/10/2006 | US20060177444 Concomitant drug as therapeutic agent for inflammatory bowel disease |
| 08/10/2006 | US20060177442 Using cytokine receptor (CD30) specific immunoglobulin to treat hodgkin's disease |
| 08/10/2006 | US20060177438 Methods of altering absorption of hydrophobic compounds |
| 08/10/2006 | US20060177430 Treatment of ocular disorders with ophthalmic formulations containing methylsulfonylmethane as a transport enhancer |
| 08/10/2006 | US20060177423 Composition and method for killing of tumours |
| 08/10/2006 | US20060177420 treatment of a tumor by administering to a patient an effective amount of active dendritic cells (DC) that are tumor-specific and secrete IL12 |
| 08/10/2006 | US20060177419 Stimulating neutrophil function to treat inflammatory bowel disease |
| 08/10/2006 | US20060177417 Packaged form containing complex of polypeptide and macromolecular carrier |
| 08/10/2006 | US20060177416 Based on biodegradable polymers containing polyester amide (PEA), polyester urethane (PEUR), and polyester urea (PEU) and immunostimulatory adjuvants; for delivery of compositions that bind to major histocompatibility complexes (MHC) alleles |
| 08/10/2006 | US20060177415 Once a day formulation for phosphate binders |
| 08/10/2006 | US20060177414 Pharmaceutical preparations for oral adminstration, containing ion-exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents |
| 08/10/2006 | US20060177413 Carbohydrate modifiers of neuronal growth |
| 08/10/2006 | US20060177402 Synthetic tear fluid |
| 08/10/2006 | US20060177400 Topical formulation for the treatment of urushiol induced contact dermatitis and method for treating the same |
| 08/10/2006 | US20060177392 Oil-based composition for acne |
| 08/10/2006 | US20060177390 Skin cancer prevention method and product |
| 08/10/2006 | US20060177385 Compositions for treating dental caries caused by streptococcus mutans infection |
| 08/10/2006 | US20060177382 Delivery of antiemetics through an inhalation route |
| 08/10/2006 | US20060177381 Opiopathies |
| 08/10/2006 | US20060177380 Methods and compositions for deterring abuse of orally administered pharmaceutical products |
| 08/10/2006 | US20060177374 Treatment of cancer with active vitamin D compounds in combination with radiotherapeutic agents and treatments |
| 08/10/2006 | DE60115222T2 Kombination von defibrotid und g-csf und ihre verwendung zur aktivierung hämatopoietischer vorläuferzellen Progenitor cell combination of defibrotide and g-csf and their use for the activation of hematopoietic |
| 08/10/2006 | DE102005005813A1 New thiazolo-indazole derivatives useful as PI3 kinase inhibitors, for treating e.g. cancer and other proliferative diseases, viral infections and inflammatory, autoimmune, skin and bone diseases |
| 08/10/2006 | DE102005005642A1 Kosmetische oder pharmazeutische Zubereitungen enthaltend Nukleinsäuren, die zur Ausbildung von stem-loop-Sekundärstrukturen geeignete Sequenzen umfassen Cosmetic or pharmaceutical preparations containing nucleic acids comprising the formation of stem-loop secondary structures suitable sequences |
| 08/10/2006 | DE102005005505A1 Use of quinazoline derivatives e.g. 4-((3-chloro-4-fluoro-phenyl)amin o)-6-(1-methanesulfonyl-piperidin-4-yloxy)-7-methoxy-quinazoline, which are tyrosine kinase inhibitors, to prevent or treat symptoms of e.g. chronic rhinosinusitis |
| 08/10/2006 | DE102005005399A1 Use of 2,4-dihydroxy-3-methylbenzoate derivatives for preparing medicaments or as basic substance for the development of other agents used for treating benign prostate hyperplasia, prostate carcinoma or spinobulbar muscular atrophy |
| 08/10/2006 | DE102005005397A1 Isolierung von N-Butylbenzolsulfonamid, Synthese von Benzolsulfonamid-Derivaten sowie Verwendung von N-Butylbenzolsulfonamid und Benzolsulfonamid-Derivaten zur Behandlung der benignen Prostatahyperplasie und/oder des Prostatakarzinoms Isolation of N-butyl benzene, synthesis of benzenesulfonamide derivatives as well as using N-butyl benzenesulfonamide and benzenesulfonamide derivatives for the treatment of benign prostatic hyperplasia and / or prostate carcinoma |
| 08/10/2006 | DE102005005395A1 New thiazolidinone compounds are polo-like kinase inhibitors, useful for treating e.g. cancer, autoimmune diseases, cardiovascular diseases, infectious diseases, nephrological diseases and viral diseases |
| 08/10/2006 | DE102005005276A1 Use of a hydroxystilbene-containing active substance combination containing resveratrol and piceatannol precursors, to prevent and/or treat diseases caused by increased serum interleukin-6 level e.g. depression |
| 08/10/2006 | DE102005005275A1 Use of a hydroxystilbene-containing active substance combination containing resveratrol and piceatannol precursors, to prevent and/or treat diseases caused by increased serum interleukin-6 level e.g. depression |
| 08/10/2006 | DE102005005274A1 Use of a hydroxystilbene-containing active substance combination containing resveratrol and piceatannol precursors, to prevent and/or treat diseases caused by increased serum interleukin-6 level e.g. depression |
| 08/10/2006 | DE102005005270A1 Use of a hydroxystilbene-containing active substance combination containing resveratrol and piceatannol precursors, to prevent and/or treat diseases caused by increased serum interleukin-6 level e.g. depression |
| 08/10/2006 | DE102005005086A1 Naturheilmittel-Nahrungsergänzungs-Kombinationspräparat Natural remedies nutritional supplements combined preparation |
| 08/10/2006 | DE102005004643A1 Antiviral combination useful for prevention and therapy of viral diseases, comprising hyaluronic acid sulfate and/or carboxyalkylated derivatives and natural substance or its extract with antiinflammatory and antiviral characteristics |
| 08/10/2006 | DE10141528B4 Platin(II)- und Platin(IV)-Komplexe und ihre Verwendung Platinum (II) - and platinum (IV) complexes and their use |
| 08/10/2006 | CA2829533A1 Contact drug delivery system |